ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

NCI Extends PRI’s Fredrick Contract Six Months

September 23, 1994

Caribbean Conference Reports Incidence Differences With U.S.

August 22, 1986

Charles Moertel, Mayo Clinic Investigator, Advocate Of Rigorous Trials, Dead At 66

July 8, 1994

Adamson Objects to IOM “Primrose Path of Centralization” In Report

March 3, 1989

NCI Grant Awards

October 8, 1993

HHS To Determine Feasibility Of CHOP Evaluation

July 24, 1981